Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance
Third quarter 2026 revenue of $21.6 million, representing 65% growth year-over-year
Covered in this story
Call it yourself
No calls on $CARL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Carlsmed Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.